Advertisement International Stem Cell signs distribution agreement with Millipore - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

International Stem Cell signs distribution agreement with Millipore

International Stem Cell, a stem-cell therapy company, has signed a worldwide distribution agreement with Millipore to manufacture living cells and cell culture products to be sold through Millipore's distribution network.

Jeffrey Janus, president of International Stem Cell, said: “This partnership will lead to a significant expansion in International Stem Cell’s revenue generation through the manufacture of high quality cells and cell culture products. The International Stem Cell-Millipore team will provide valuable research tools for cell biologists across the world.”